Analyst Price Target is $3.50
▲ +142.21% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for XpresSpa Group in the last 3 months. The average price target is $3.50, with a high forecast of $3.50 and a low forecast of $3.50. The average price target represents a 142.21% upside from the last price of $1.45.
Current Consensus is
The current consensus among 1 investment analysts is to buy stock in XpresSpa Group.
XpresSpa Group, Inc., a health and wellness services company, provides spa services at airports. It operates in two segments, XpresSpa and XpresTest. The company offers spa services, including massage, and nail and skin care, as well as spa and travel products; and retail products. XpresSpa Group, Inc., through its subsidiary XpresTest, Inc., operates wellness centers that provides COVID-19 screening and testing, and rapid testing services for other communicable diseases, such as influenza, mononucleosis and group A streptococcus, and seasonal flu vaccination services; and other medical diagnostic testing services under the XpresCheck brand. As of March 31, 2021, it provided its services through 45 locations in 23 airports worldwide; and wellness centers in 5 domestic airport locations. The company was formerly known as FORM Holdings Corp. and changed its name to XpresSpa Group, Inc. in January 2018. XpresSpa Group, Inc. is headquartered in New York, New York.